Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome

Title: Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
Authors: Wendel, Eva Maria; Thonke, Helen Sophie; Bertolini, Annikki; Baumann, Matthias; Blaschek, Astrid; Merkenschlager, Andreas; Karenfort, Michael; Kornek, Barbara; Lechner, Christian; Pohl, Daniela; Pritsch, Martin; Schanda, Kathrin; Schimmel, Mareike; Thiels, Charlotte; Waltz, Stephan; Wiegand, Gert; Anlar, Banu; Barisic, Nina; Blank, Christian; Breu, Markus; Broser, Philip; Della Marina, Adela; Diepold, Katharina; Eckenweiler, Matthias; Eisenkölbl, Astrid; Freilinger, Michael; Gruber-Sedlmayr, Ursula; Hackenberg, Annette; Iff, Tobias; Knierim, Ellen; Koch, Johannes; Kutschke, Georg; Leiz, Steffen; Lischetzki, Grischa; Nosadini, Margherita; Pschibul, Alexander; Reiter-Fink, Edith; Rohrbach, Doris; Salandin, Michela; Sartori, Stefano; Schlump, Jan-Ulrich; Stoffels, Johannes; Strautmanis, Jurgis; Tibussek, Daniel; Tüngler, Victoria; Utzig, Norbert; Reindl, Markus; Rostásy, Kevin
Contributors: Wendel, Eva Maria; Thonke, Helen Sophie; Bertolini, Annikki; Baumann, Matthia; Blaschek, Astrid; Merkenschlager, Andrea; Karenfort, Michael; Kornek, Barbara; Lechner, Christian; Pohl, Daniela; Pritsch, Martin; Schanda, Kathrin; Schimmel, Mareike; Thiels, Charlotte; Waltz, Stephan; Wiegand, Gert; Anlar, Banu; Barisic, Nina; Blank, Christian; Breu, Marku; Broser, Philip; Della Marina, Adela; Diepold, Katharina; Eckenweiler, Matthia; Eisenkölbl, Astrid; Freilinger, Michael; Gruber-Sedlmayr, Ursula; Hackenberg, Annette; Iff, Tobia; Knierim, Ellen; Koch, Johanne; Kutschke, Georg; Leiz, Steffen; Lischetzki, Grischa; Nosadini, Margherita; Pschibul, Alexander; Reiter-Fink, Edith; Rohrbach, Dori; Salandin, Michela; Sartori, Stefano; Schlump, Jan-Ulrich; Stoffels, Johanne; Strautmanis, Jurgi; Tibussek, Daniel; Tüngler, Victoria; Utzig, Norbert; Reindl, Marku; Rostásy, Kevin
Publisher Information: LIPPINCOTT WILLIAMS & WILKINS
Publication Year: 2022
Collection: Padua Research Archive (IRIS - Università degli Studi di Padova)
Subject Terms: MOG; antibody; demyelination; children
Description: Background and Objective The spectrum of myelin oligodendrocyte glycoprotein (MOG) antibody-associated disorder (MOGAD) comprises monophasic diseases such as acute disseminated encephalomyelitis (ADEM), optic neuritis (ON), and transverse myelitis and relapsing courses of these presentations. Persistently high MOG antibodies (MOG immunoglobulin G [IgG]) are found in patients with a relapsing disease course. Prognostic factors to determine the clinical course of children with a first MOGAD are still lacking. The objective of the study is to assess the clinical and laboratory prognostic parameters for a risk of relapse and the temporal dynamics of MOG-IgG titers in children with MOGAD in correlation with clinical presentation and disease course. Methods In this prospective multicenter hospital-based study, children with a first demyelinating attack and complete data set comprising clinical and radiologic findings, MOG-IgG titer at onset, and clinical and serologic follow-up data were included. Serum samples were analyzed by live cell-based assay, and a titer level of >= 1:160 was classified as MOG-IgG-positive. Results One hundred sixteen children (f:m = 57:59) with MOGAD were included and initially diagnosed with ADEM (n = 59), unilateral ON (n = 12), bilateral ON (n = 16), myelitis (n = 6), neuromyelitis optica spectrum disorder (n = 8) or encephalitis (n = 6). The median follow-up time was 3 years in monophasic and 5 years in relapsing patients. There was no significant association between disease course and MOG-IgG titers at onset, sex, age at presentation, or clinical phenotype. Seroconversion to MOG-IgG-negative within 2 years of the initial event showed a significant risk reduction for a relapsing disease course. Forty-two/one hundred sixteen patients (monophasic n = 26, relapsing n = 16) had serial MOG-IgG testing in years 1 and 2 after the initial event. In contrast to relapsing patients, monophasic patients showed a significant decrease of MOG-IgG titers during the first and second years, often with ...
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/36229191; info:eu-repo/semantics/altIdentifier/wos/WOS:000874687300014; volume:9; issue:6; numberofpages:11; journal:NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION; https://hdl.handle.net/11577/3464541; https://pubmed.ncbi.nlm.nih.gov/36229191/
DOI: 10.1212/NXI.0000000000200035
Availability: https://hdl.handle.net/11577/3464541; https://doi.org/10.1212/NXI.0000000000200035; https://pubmed.ncbi.nlm.nih.gov/36229191/
Rights: info:eu-repo/semantics/openAccess ; license:Creative commons ; license uri:http://creativecommons.org/licenses/by-nc-nd/4.0/
Accession Number: edsbas.8D00AE27
Database: BASE